Company intelligence / Profile preview
Steadfast Limited
New Delhi, Delhi, Indiasteadfastmedishield.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Steadfast Medishield is a prominent Indian pharmaceutical and healthcare company specializing in renal care and organ transplantation. The company provides a comprehensive portfolio of products including immunosuppressants, erythropoietin stimulating agents, and phosphate binders designed to manage chronic kidney disease and post-transplant recovery. Beyond pharmaceuticals, Steadfast Medishield is known for its patient-centric approach, offering support services and educational resources for the renal community. The company operates as a key player in the Indian nephrology market, focusing on high-quality, affordable treatments for life-threatening conditions.
- Therapeutic areas
- ImmunologyNephrologyHematology
- Modalities
- Small moleculeBiologicProtein
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Steadfast Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Steadfast Limited.